Race against time: new hope for stroke patients when standard treatment Isn't available
NCT ID NCT07168278
Summary
This study tests whether the clot-busting drug tenecteplase can help stroke patients who arrive at the hospital 4.5 to 24 hours after symptoms begin, when the standard mechanical clot removal procedure isn't available. Researchers will compare giving the drug against standard medical care alone in 794 participants to see if it improves recovery and independence 90 days after the stroke. The goal is to provide an effective treatment option for patients who currently have limited choices due to timing or lack of access to specialized procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.